Profil

Delattre Luc

Département de pharmacie

See author's contact details
Main Referenced Co-authors
Evrard, Brigitte  (161)
Piel, Géraldine  (110)
Van Hees, Thierry  (36)
Barillaro, Valery (24)
Bertholet, Pascal (24)
Main Referenced Keywords
cyclodextrin (5); Cyclodextrins (5); cyclodextrins (5); Miconazole (5); Molecular modeling (5);
Main Referenced Unit & Research Centers
C.I.R.M. (4)
CEIB - Centre Interfacultaire des Biomatériaux - ULiège [BE] (1)
Center for Education and Research on Macromolecules (CERM) (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (174)
Chemistry (14)
Biochemistry, biophysics & molecular biology (3)
Physical, chemical, mathematical & earth Sciences: Multidisciplinary, general & others (3)
Reproductive medicine (gynecology, andrology, obstetrics) (2)

Publications (total 184)

The most downloaded
740 downloads
Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010 https://hdl.handle.net/2268/12042

The most cited

209 citations (Scopus®)

Roland, I., Piel, G., Delattre, L., & Evrard, B. (16 September 2003). Systematic characterization of oil-in-water emulsions for formulation design. International Journal of Pharmaceutics, 263 (1-2), 85-94. doi:10.1016/S0378-5173(03)00364-8 https://hdl.handle.net/2268/18717

Belhadj Salem, L., Bosquillon, C., Dailey, L. A., Delattre, L., Martin, G. P., Evrard, B., & Forbes, B. (2009). Sparing methylation of β-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. Journal of Controlled Release, 136, 110-116. doi:10.1016/j.jconrel.2009.01.019
Peer Reviewed verified by ORBi

Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (2009). Study of the cholesterol extraction capacity of β-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 63 (3-4), 225-231. doi:10.1007/s10847-008-9510-9
Peer reviewed

Noël, A., Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., & Foidart, J.-M. (27 November 2008). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS.

Defrère, S., Squifflet, J., Lousse, J. C., Van Langendonck, A., Gonzalez-Ramos, R., Foidart, J.-M., Jérôme, C., Delattre, L., Donnez, J., & Dehoux, J. P. (April 2008). Unsuccessful Induction of Endometriosis in Female Rhesus Macaques (Macaca mulatta). Gynecologic and Obstetric Investigation, 66 (2), 84-90. doi:10.1159/000127447
Peer Reviewed verified by ORBi

Barillaro, V., Dive, G., Ziemons, E., Bertholet, P., Evrard, B., Delattre, L., & Piel, G. (10 February 2008). Theoretical and Experimental Vibrational Study of Miconazole and Its Dimers with Organic Acids: Application to the IR Characterization of Its Inclusion Complexes with Cyclodextrins. International Journal of Pharmaceutics, 350 (1-2), 155-165. doi:10.1016/j.ijpharm.2007.08.048
Peer Reviewed verified by ORBi

Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Frederich, M., Ziemons, E., & Piel, G. (22 January 2008). Theoretical and Experimental Investigations of Organic Acids/Cyclodextrin Complexes and Their Consequences Upon the Formation of Miconazole/Cyclodextrin/Acid Ternary Inclusion Complexes. International Journal of Pharmaceutics, 347 (1-2), 62-70. doi:10.1016/j.ijpharm.2007.06.030
Peer Reviewed verified by ORBi

Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (November 2007). Interaction de la b-cyclodextrine et de ses dérivés avec des cellules endothéliales: dosage du cholestérol résiduel [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Bodson, C., Rozet, E., Ziemons, E., Evrard, B., Hubert, P., & Delattre, L. (18 October 2007). Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (NIRS). Journal of Pharmaceutical and Biomedical Analysis, 45 (2), 356-361. doi:10.1016/j.jpba.2007.05.015
Peer Reviewed verified by ORBi

Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Castagne, D., Delattre, L., Evrard, B., Fillet, M., Nusgens, B., & Piel, G. (October 2007). Cell membrane destructuration using cyclodextrins: effect on cholesterol content of endothelial cells [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (October 2007). Characterization of siRNA lipoplexes in terms of size and zeta potential data [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Krell, H.-W., Cataldo, D., Delattre, L., Evrard, B., & Foidart, J.-M. (27 September 2007). USE OF A TRIOXOPYRIMIDINE FOR THE TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (29 June 2007). Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. International Journal of Pharmaceutics, 338 (1-2), 35-42. doi:10.1016/j.ijpharm.2007.01.015
Peer Reviewed verified by ORBi

Tursilli, R., Piel, G., Delattre, L., & Scalia, S. (June 2007). Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: Effect of the vehicle. European Journal of Pharmaceutics and Biopharmaceutics, 66 (3), 483-487. doi:10.1016/j.ejpb.2007.02.017
Peer Reviewed verified by ORBi

Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (April 2007). Evaluation of the cytotoxicity of cyclodextrins on endothelial cells using MTT assay [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands.

Piette, M., Castagne, D., Delattre, L., & Piel, G. (April 2007). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 101-103. doi:10.1007/s10847-006-9214-y
Peer reviewed

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (April 2007). Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 309-311. doi:10.1007/s10847-006-9178-y
Peer reviewed

Ziemons, E., Dive, G., Debrus, B., Barillaro, V., Frederich, M., Lejeune, R., Angenot, L., Delattre, L., Thunus, L., & Hubert, P. (February 2007). Study of the physicochemical properties in aqueous medium and molecular modeling of tagitinin C/cyclodextrin complexes. Journal of Pharmaceutical and Biomedical Analysis, 43 (3), 910-919. doi:10.1016/j.jpba.2006.09.011
Peer Reviewed verified by ORBi

Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimisation de la réaction de complexation entre une cyclodextrine et un composé pharmaceutique par utilisation du CO2 supercritque [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Jaspart, S., Bertholet, P., Piel, G., Dogné, J.-M., Delattre, L., & Evrard, B. (January 2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 65 (1), 47-56. doi:10.1016/j.ejpb.2006.07.006
Peer Reviewed verified by ORBi

Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Development of an original intra-uterine implant allowed specific release kinetics of several drugs [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Krier, F., Nizet, D., Riva, R., colombo, M., Frankenne, F., Jérôme, C., Piel, G., Delattre, L., & Evrard, B. (2007). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimization of drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide method [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Maquet, V., Delattre, L., & Evrard, B. (2007). Controlled release of drugs from an original multi-component device [Poster presentation]. Biomedica 2007, aachen, Germany.

Jaspart, S., Delattre, L., & Evrard, B. (2007). Formulation and in vitro evaluation of inhalable dry powders containing solid lipid nanoparticles [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (2007). Studies on the structure of cationic liposomes/siRNA complexes by zeta potential and size measurement [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z
Peer Reviewed verified by ORBi

Nizet, D., Jaspart, S., Brion, M., Piel, G., Delattre, L., & Evrard, B. (2007). Supercritical fluid technology to produce solid lipid microparticles [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Belhadj Salem, L., Bosquillon, C., Delattre, L., Martin, G., Evrard, B., & Forbes, B. (2007). Kleptose Crysmeb is a biocompatiblecyclodextrin solubiliser for pulmonary delivery of Ro 28-2653, a new synthetix matrix metalloproteinase inhibitor [Poster presentation]. Pharmaceutical Sciences World Congress.

Belhadj-Salem, L., Bosquillon, C., Delattre, L., Martin, G., Forbes, B., & Evrard, B. (2007). Effect of cyclodextrin derivatives on bronchial epithelial cell layer permeability [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Nizet, D., Zalfen, A., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Controlled release of drug from multicomponent device [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands.

Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Ziemons, E., & Piel, G. (2007). Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. International Journal of Pharmaceutics, 342 (1-2), 152-160. doi:10.1016/j.ijpharm.2007.05.003
Peer Reviewed verified by ORBi

Castagne, D., Belhadj Salem, L., Delattre, L., Nusgens, B., & Piel, G. (2007). Effect of cyclodextrins on the viability of endothelial cells. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 105-107. doi:10.1007/s10847-006-9211-1
Peer reviewed

Hubert, P., Evrard, B., Delattre, L., Boniver, J., Delvenne, P., Noël, A., Frankenne, F., & Foidart, J.-M. (12 December 2006). Mucoadhesive composition comprising polyacrylate and chemoattractant.

Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Lumay, G., Vandewalle, N., Delattre, L., Gerasimov, O., & Bodson, C. (28 August 2006). Linking compaction dynamics to the flow properties of powders. Applied Physics Letters, 89 (9). doi:10.1063/1.2338801
Peer Reviewed verified by ORBi

Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., Noël, A., & Foidart, J.-M. (28 June 2006). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS.

Bodson, C., Dewé, W., Hubert, P., & Delattre, L. (07 June 2006). Comparison of FT-NIR transmission and UV-vis spectrophotometry to follow the mixing kinetics and to assay low-dose tablets containing riboflavin. Journal of Pharmaceutical and Biomedical Analysis, 41 (3), 783-790. doi:10.1016/j.jpba.2006.01.022
Peer Reviewed verified by ORBi

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011
Peer Reviewed verified by ORBi

Piette, M., Castagne, D., Delattre, L., & Piel, G. (May 2006). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes [Poster presentation]. 13th International Cyclodextrin Symposium, Turin, Italy.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044
Peer Reviewed verified by ORBi

Bosquillon, C, Belhadj Salem, L, Hernandez, E, Martin, G.P, Delattre, L., Evrard, B., & Forbes, B. (2006). Effect of ß-Cyclodextrin Derivatives on Bronchial Epithelial Cell Layer Permeability. Delivery to the lung, 17, 90-93.
Peer reviewed

Zalfen, A., Nizet, D., Jérôme, C., Delattre, L., Frankenne, F., & Evrard, B. (2006). Multi-biomaterial for controlled release of active substances [Poster presentation]. European conference on Biomaterials, Nantes, France.

Tursilli, R., Scalia, S., Piel, G., Jaspart, S., & Delattre, L. (2006). Encapsulation of the sunscreen agent, octyl dimethyl PABA, in lipid microparticles: effect on photostability [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Stassen, T., Piette, M., Kinget, R., & Delattre, L. (2006). Etude des performances d'appareils de melange Unguator pour la preparation magistrale a usage dermatologique. Journal de Pharmacie de Belgique, 61 (1), 1-10.
Peer Reviewed verified by ORBi

Barillaro, V., Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (2006). Application of supercritical carbon dioxide to the preparation of inclusion complexes into cyclodextrins [Paper presentation]. 13th International Pharmaceutical Technology Symposium, Antalya, Turkey.

Kirschvink, N, Leemans, J., Delvaux, F., Snaps, F., Jaspart, S., Evrard, B., Delattre, L., Cambier, C., Clercx, C., & Gustin, P. (2006). Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. Journal of Feline Medicine and Surgery, 8 (1), 45-54. doi:10.1016/j.jfms.2005.07.001
Peer Reviewed verified by ORBi

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (2006). Study of the interaction between cyclodextrins and liposomes membranes: effect on the permeability of liposomes [Paper presentation]. XIII th International Cyclodextrin Symposium, Torino, Italy.

Delporte, J.-P., Delattre, L., & Herné, P. (2006). Le point sur les medicaments generiques et sur la prescription sous denomination commune. Revue Médicale de Liège, 61 (5-6, May-Jun), 459-63.
Peer reviewed

Patel, J., Belhadj Salem, Martin, G. P., Delattre, L., Evrard, B., Forbes, B., & Bosquillon, C. (2006). Use of the MTT assay to evaluate the biocompatibility of beta-cyclodextrin derivatives with respiratory epithelial cells. Journal of Pharmacy and Pharmacology, 58 (58), 64-65.
Peer Reviewed verified by ORBi

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (November 2005). Effect of cyclodextrins on the membrane permeability of liposomes [Poster presentation]. 2nd EUFEPS conference on optimising drug delivery and formulation, Versailles, France.

Barillaro, V., Bertholet, P., Evrard, B., Delattre, L., Dive, G., & Piel, G. (September 2005). Inclusion of miconazole into cyclodextrins by means of supercritical carbon dioxide: effect of acidic ternary compound and molecular modelling study [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (September 2005). Encapsulation of betamethasone-cyclodextrin inclusion complexes in liposmes: effect of cyclodextrins on the encapsulation efficinecy and the kinetic release of betamethasone [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

bodson, C., Hubert, P., & Delattre, L. (12 June 2005). instrumentation of a high shear mixer for in-line monitoring of a pharmaceutical blending process using FT-NIR spectroscopy [Paper presentation]. PharmSciFair, Nice, France.

Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Piel, G., Boulmedarat, L., Bochot, A., Lesieur, S., Delattre, L., & Fattal, E. (June 2005). Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharmaceutical Research, 22 (6), 962-971. doi:10.1007/s11095-005-4591-2
Peer Reviewed verified by ORBi

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2005). Pharmacokinetic study of a new syntheyic MMP inhibitor (Ro 28-2653) after IV and oral administration of solutions containing hydroxypropyl-b-cyclodextrin [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

bodson, C., Hubert, P., & Delattre, L. (20 May 2005). instrumentation of a high shear mixer for in-line monitoring of a pharmaceutical blending process using FT-NIR spectroscopy.

Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042
Peer Reviewed verified by ORBi

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (March 2005). Influence des cyclodextrines sur la vitesse de libération de la bétamethasone encapsulée sous forme de complexe dans des liposomes [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (March 2005). Etude pharmacocinétique d'un nouvel inhibiteur des MMPs (I-col 51) après administration orale et intraveineuse de soultions à base d'hydroxypropyl-b-cyclodextrine [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Bertholet, P., Guéders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Piel, G., Delattre, L., & Evrard, B. (2005). The Effect of Cyclodextrins on the Aqueous Solubility of a New Mmp Inhibitor: Phase Solubility, 1 H-Nmr Spectroscopy and Molecular Modeling Studies, Preparation and Stability Study of Nebulizable Solutions. Journal of Pharmacy and Pharmaceutical Sciences, 8 (2), 164-175.
Peer Reviewed verified by ORBi

Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75
Peer Reviewed verified by ORBi

Jaspart, S., Bodson, C., Bertholet, P., Delattre, L., & Evrard, B. (2005). In vitro release of salbutamol acetonide from solid lipid nanoparticles. In Proceedings of 1st Pharmaceutical Sciences Fair and Exhibition.
Peer reviewed

Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (2005). Evaluation of the pulmonary inflammation and bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins. In Journal of inclusion Phenomena and Macrocyclic Chesmistry.
Peer reviewed

Barillaro, V., Evrard, B., Delattre, L., & Piel, G. (2005). Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS Journal, 7 (1), 149-E155. doi:10.1208/aapsj070116
Peer Reviewed verified by ORBi

Jaspart, S., Bertholet, P., Delattre, L., & Evrard, B. (2005). Study of solid lipid micriparticles as sustained release delivery system for pulmonary administration [Paper presentation]. 15th International symposium on microencapsulation, Parma, Italy.

Barillaro, V., Bertholet, P., Henry de Hassonville, S., Ziemons, E., Evrard, B., Delattre, L., & Piel, G. (30 November 2004). Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, 7 (3), 378-388.
Peer reviewed

Henry de Hassonville, S., Chiap, P., Liégeois, J.-F., Evrard, B., Delattre, L., Crommen, J., Piel, G., & Hubert, P. (21 September 2004). Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. Journal of Pharmaceutical and Biomedical Analysis, 36 (1), 133-143. doi:10.1016/j.jpba.2004.05.023
Peer Reviewed verified by ORBi

Roland, I., de Leval, X., Evrard, B., Pirotte, B., Dogné, J.-M., & Delattre, L. (August 2004). Modulation of the arachidonic cascade with omega 3 fatty acids or analogues: Potential therapeutic benefits. Mini Reviews in Medicinal Chemistry, 4 (6), 659-668. doi:10.2174/1389557043403738
Peer Reviewed verified by ORBi

Piel, G., Boulmedarat, L., Bochot, A., Delattre, L., & Fattal, E. (May 2004). Influence of methyl-b-cyclodextrin on the relase kinetics of inulin encapsulated in bioadhesive liposomes [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (May 2004). Effect of methylated-b-cyclodextrin on the skin and influence on cyproterone acetate percutaneous absorption [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (May 2004). Evaluation of the pulmonary inflammation and the bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins [Paper presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2004). Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrobial Agents and Chemotherapy, 48 (11), 4342-4348. doi:10.1128/AAC.48.11.4342-4348.2004
Peer Reviewed verified by ORBi

Jaspart, S., Kirschvink, N., Chiap, P., Delattre, L., Crommen, J., Gustin, P., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters and preliminary tolerance study [Paper presentation]. 12eme Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Henry de Hassonville, S., Dive, G., Evrard, B., Barillaro, V., Bertholet, P., Delattre, L., & Piel, G. (2004). Application of molecular modeling to the study of cyproterone acetate stability in the presence of cyclodextrin derivatives. Journal of Drug Delivery Science and Technology, 14 (5, SEP-OCT), 357-362. doi:10.1016/s1773-2247(04)50064-3
Peer reviewed

Piel, G., Moutard, S., Perly, B., Henry de Hassonville, S., Bertholet, P., Barillaro, V., Piette, M., Delattre, L., & Evrard, B. (2004). Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. Journal of Drug Delivery Science and Technology, 14 (1, JAN-FEB), 87-91. doi:10.1016/s1773-2247(04)50010-2
Peer reviewed

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004
Peer Reviewed verified by ORBi

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (January 2004). Etude des interactions cyclodextrines-liposomes: modification de la cinétique de libération de l'inuline encapsulée dans des lioposomes bioadhésifs en présence de méthyl-b-cyclodextrine [Paper presentation]. 7èmes Journées du Club français des Cyclodextrines, Lille, France.

Evrard, B., Hubert, P., Delvenne, P., Boniver, J., & Delattre, L. (2004). Development of a hydrogel containing GM-CSF to improve the dendritic cells colonisation of HPV+ epithelium. In Proceedings of Eur conference on drug delivery and pharmaceutical technology.
Peer reviewed

Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010
Peer Reviewed verified by ORBi

Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., & Evrard, B. (2004). Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSci, 5 (2), 27. doi:10.1208/pt050227
Peer Reviewed verified by ORBi

Jaspart, S., Bodson, C., Bertholet, P., Chiap, P., Delattre, L., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters [Paper presentation]. European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2004). La Rameb, un promoteur d’absorption cutanée pour l’acétate de cypro-térone ? [Paper presentation]. 7e journées du club cyclodextrines, Lille, France.

Roland, I., Gillard, P., Delattre, L., Evrard, B., & de LA BRASSINNE, M. (2004). Characterisation of a novel topical nanoemulsion vehicle with spreading properties. In Proceedings of Eur conference on drug delivery and pharmaceutical technology.
Peer reviewed

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (October 2003). The skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Poster presentation]. Skin and Formulation, 1st Symposium, Paris, France.

Roland, I., Piel, G., Delattre, L., & Evrard, B. (16 September 2003). Systematic characterization of oil-in-water emulsions for formulation design. International Journal of Pharmaceutics, 263 (1-2), 85-94. doi:10.1016/S0378-5173(03)00364-8
Peer Reviewed verified by ORBi

Delattre, L., Henry de Hassonville, S., & Evrard, B. (04 June 2003). Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof.

Bertolla, C., Piette, M., Evrard, B., Delattre, L., Piel, G., Frédérick, R., & Masereel, B. (May 2003). Synthèse de b-cyclodextrines modifiées [Poster presentation]. 17th Journées Franco-belges de Pharmacochimie, Bruxelles, Belgium.

Roland, I., Piel, G., Delattre, L., & Evrard, B. (May 2003). Systematic characterization of oil-in-water emulsion for formulation design [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Bertholet, P., Cataldo, D., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., & Evrard, B. (May 2003). Effect of inhaled cyclodextrins on the pulmonary inflammation and bronchial hyperresponsiveness in mice [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Henry de Hassonville, S., Dive, G., Prosperi, C., Perly, B., Piel, G., Barillaro, V., Bertholet, P., Delattre, L., Llabres, G., & Evrard, B. (May 2003). Influence of cyclodextrins on the solubility and the stability of cyproterone acetate [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (May 2003). An ex-vivo study of the skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2003). Cyclodextrins as topical permeation enhancers : in vitro and in vivo testing [Poster presentation]. Symposium skin and formulation APGI, Paris, France.

Barillaro, V., Van Hees, T., Bertini, S., Piel, G., Bertholet, P., Henry de Hassonville, S., Evrard, B., & Delattre, L. (January 2003). Etude de l'inclusion du miconazole dans les cyclodextrines par le CO2 supercritique: caracterisation des complexes par HPLC, CP-MAS-NMR et FT-IR [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., & Evrard, B. (2003). Solid lipid Nanoparticles for drug Pumonary Administration. In Proceedings of 30th International Symposium on Controlled Release of Bioactive Materials.
Peer reviewed

Roland, I, Evrard, B., Erpicum, T, & Delattre, L. (2003). Formulation of submicronic emulsions by using a high-pressure homogeniser. Journal de Pharmacie de Belgique, 57, 68-70.
Peer Reviewed verified by ORBi

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (January 2003). Etude comparative de la tolérance cutanée de nouveaux dérivés amphiphiles de cyclodextrines: les phospholipidyl-cyclodextines [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Bertholet, P., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (January 2003). Etude de l'hyperactivité bronchique induite par l'administration pulmonaire de cyclodextrines chez la souris [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Roland, I., Gillard, P., Delattre, L., Evrard, B., & de LA BRASSINNE, M. (2003). Formulation and evaluation of a novel topical nanoemulsion vehicle with spreading properties [Poster presentation]. Symposium Skin and formulation, Paris, France.

Evrard, B., Chiap, P., De Tullio, P., Ghalmi, F., Piel, G., Van Hees, T., Crommen, J., Losson, B., & Delattre, L. (13 December 2002). Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Journal of Controlled Release, 85 (1-3), 45-50. doi:10.1016/S0168-3659(02)00270-5
Peer Reviewed verified by ORBi

Van Hees, T., Barillaro, V., Piel, G., Bertholet, P., De Hassonville, S., Evrard, B., & Delattre, L. (December 2002). Application of Supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44 (1-4), 271-274. doi:10.1023/A:1023084617964
Peer reviewed

Van Hees, T., Piel, G., Henry de Hassonville, S., Evrard, B., & Delattre, L. (May 2002). Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. European Journal of Pharmaceutical Sciences, 15 (4), 347-353. doi:10.1016/S0928-0987(02)00018-0
Peer Reviewed verified by ORBi

Piel, G., Moutard, S., Van Hees, T., Henry de Hassonville, S., Delattre, L., & Evrard, B. (April 2002). Determination of the interaction between cyclodextins and drugs: comparison of two methods (phase solubility diagrams and NMR) [Poster presentation]. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Firenze, Italy.

Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Barillaro, V., Betholet, P., Evrard, B., & Delattre, L. (February 2002). Augmentation de la solubilité de l'acétate de cyprotérone par formation de complexes d'inclusion dans les cyclodextrines [Paper presentation]. 5èmes Journées du Club français des Cyclodextrines, Amiens, France.

Barillaro, V., Van Hees, T., Piel, G., Henry de Hassonville, S., Bertholet, P., Evrard, B., & Delattre, L. (February 2002). Influence de l'ajout d'un composé ternaire dans la formation d'un complexe d'inclusion de miconazole dans les cyclodextrines par CO2 supercritique [Paper presentation]. 5ème Journée du Club français des Cyclodextrines, Amiens, France.

Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Delattre, L., & Evrard, B. (2002). Inclusion Complexes of Cyproterone Acetate with Cyclodextrins in Aqueous Solution. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44, 289-292. doi:10.1023/A:1023099611604
Peer reviewed

Otte, X, Evrard, B., Delattre, L., & Thunus, L. (2002). Development and validation of a new Fourier transform infrared spectrometric method for the quantification of urea in creams and ointments. Analytica Chimica Acta, 451, 323-328. doi:10.1016/S0003-2670(01)01416-7
Peer Reviewed verified by ORBi

Piel, G., Hayette, M.-P., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., De Mol, P., & Delattre, L. (July 2001). In Vitro Comparison of the Antimycotic Activity of a Miconazole-Hp-Beta-Cyclodextrin Solution with a Miconazole Surfactant Solution. Journal of Antimicrobial Chemotherapy, 48 (1), 83-7. doi:10.1093/jac/48.1.83
Peer Reviewed verified by ORBi

Piel, G., Dive, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (June 2001). Molecular Modeling Study of Beta- and Gamma-Cyclodextrin Complexes with Miconazole. European Journal of Pharmaceutical Sciences, 13 (3), 271-9. doi:10.1016/S0928-0987(01)00113-0
Peer Reviewed verified by ORBi

Roland, I., Evrard, B., Erpicum, T., & Delattre, L. (2001). Formulation of subcronic emulsions by using a high-pressure homogeniser [Paper presentation]. 10th Forum of Pharmaceutical Sciences, Montreal, Canada.

Alvarez, C, Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J.J, & Delattre, L. (2001). Préparation de complexes mebendazole-HPβCD à l'aide de polymères solubles dans l'eau et d'acides organiques. Annales Pharmaceutiques Françaises, 59, 380.
Peer Reviewed verified by ORBi

Roland, I., Evrard, B., Erpicum, T., & Delattre, L. (2001). Formulation and characterisation of submicronic emulsions [Paper presentation]. International Symposium on Material Characterisation an Technology, Bruxelles, Belgium.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Delattre, L., & Evrard, B. (2001). Preparation of mebendazole HP-beta-cyclodextrin complexes using water-soluble polymers and organic acids. STP Pharma Sciences, 11 (6), 439-442.
Peer reviewed

Piel, G., Llabres, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (2001). A nuclear magnetic resonance study of the miconazole-b-cyclodextrin inclusion complex in an acidic medium: determination of the structure and stability constants. STP Pharma Sciences, 11 (3), 235-238.
Peer reviewed

Gautier, S., Grudzielski, N., Goffinet, G., Henry de Hassonville, S., Delattre, L., & Jérôme, R. (2001). Preparation of poly(D,L-lactide) nanoparticles assisted by amphiphilic poly(methyl methacrylate-co-methacrylic acid) copolymers. Journal of Biomaterials Science. Polymer Edition, 12 (4), 429-450. doi:10.1163/156856201750195306
Peer Reviewed verified by ORBi

Piel, G., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (December 2000). Etude comparative de l'effet de différents acides et de différentes cyclodextrines sur la solubilité du miconazole, du kétoconazole et de l'itraconazole [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France.

Van Hees, T., Piel, G., Evrard, B., Henry de Hassonville, S., & Delattre, L. (December 2000). Solubility of p-hydroxybenzoic esters in supercritical carbon dioxide [Poster presentation]. 7th Meeting on Supercritical Fluids, Antibes, France.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (December 2000). Préparation de complexes mébendazole-HPbCD à l'aide de polymères solubles dans l'eau et d'acides organiques [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (May 2000). Development of a cutaneous hydrogel containing miconazole by the useof hydroxypropyl-b-cyclodextrin and lactic acid [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States.

Piel, G., Evrard, B., Van Hees, T., Hayette, M.-P., De Mol, P., & Delattre, L. (May 2000). Development of a new parenteral solution of miconazole by the use of cyclodextrins derivatives [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (April 2000). Preparation of mebendazole HP-b-cyclodextrin complexes using water soluble polymers and organic acids [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Chiap, P., Evrard, B., Bimazubute, M. A., De Tullio, P., Hubert, P., Delattre, L., & Crommen, J. (10 February 2000). Determination of Albendazole and Its Main Metabolites in Ovine Plasma by Liquid Chromatography with Dialysis as an Integrated Sample Preparation Technique. Journal of Chromatography. A, 870 (1-2), 121-34. doi:10.1016/S0021-9673(99)00938-3
Peer Reviewed verified by ORBi

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (2000). Inclusion of Piroxicam into Beta-Cyclodextrin by Means of Supercritical Carbon Dioxide: Thermal, Spectroscopic and Physicochemical Studies. Journal de Pharmacie de Belgique, 55 (1, Jan-Feb), 30-1.

Van Hees, T., Piel, G., Evrard, B., Otte, X., Thunus, L., & Delattre, L. (December 1999). Application of Supercritical Carbon Dioxide for the Preparation of a Piroxicam-Beta-Cyclodextrin Inclusion Compound. Pharmaceutical Research, 16 (12), 1864-70. doi:10.1023/A:1018955410414
Peer Reviewed verified by ORBi

Evrard, B., Amighi, K., Beten, D., Delattre, L., & Moes, A. J. (November 1999). Influence of Melting and Rheological Properties of Fatty Binders on the Melt Granulation Process in a High-Shear Mixer. Drug Development and Industrial Pharmacy, 25 (11), 1177-84. doi:10.1081/DDC-100102285
Peer Reviewed verified by ORBi

Evrard, B., & Delattre, L. (06 October 1999). SUSTAINED RELEASE PHARMACEUTICAL TABLETS WITH TRAMADOL BASE AND THEIR PREPARATION.

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (May 1999). Inclusion of piroxicam into b-cyclodextrin by means of supercritical carbon dioxide: thermal, spectroscopic and physicochemical studies [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Piel, G., Evrard, B., Van Hees, T., & Delattre, L. (25 March 1999). Comparison of the Iv Pharmacokinetics in Sheep of Miconazole-Cyclodextrin Solutions and a Micellar Solution. International Journal of Pharmaceutics, 180 (1), 41-5. doi:10.1016/S0378-5173(98)00403-7
Peer Reviewed verified by ORBi

Chiap, P., Hubert, P., Bimazubute, M., Evrard, B., Delattre, L., & Crommen, J. (1999). LC determination of albendazole and its main metabolites in ovine plasma using dialysis as integrated sample preparation technique [Poster presentation]. XXIIIrd International Symposium on High Performance Liquid Phase Separations and Related Techniques, Grenade, Spain.

Piel, G., Evrard, B., Van Hees, T., Llabres, G., & Delattre, L. (1999). Development of a parenteral and of an oral formulation of albendazole with cyclodextrins. STP Pharma Sciences, 3, 257-260.
Peer reviewed

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (1999). A Comparative Study of the Antimycotic Activity of a Miconazole Hp-Beta Cyclodextrin Solution and a Surfactant Solution. Journal de Pharmacie de Belgique, 54 (3, May-Jun), 87-8.

Chiap, P., Evrard, B., Bimazubute, M., De Tullio, P., Hubert, P., Delattre, L., & Crommen, J. (1999). On-line combinaison of dialysis with liquid chromatography for the automated determination of albendazole and its main metabolites in ovine plasma [Paper presentation]. VIIIème Forum des Sciences Pharmaceutiques, Spa, Belgium.

Evrard, B., De Tullio, P., Chiap, P., Van Hees, T., Piel, G., Crommen, J., Losson, B., & Delattre, L. (1999). The effect of hydroxypropyl-b-cyclodextrins on the pharamacokinetics of albendazole in sheep. In Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials.
Peer reviewed

Chiap, P., Planck, I., Evrard, B., Hubert, P., Delattre, L., & Crommen, J. (1998). Automated determination of acyclovir in human plasma using solid phase extraction and liquid chromatography. Journal de Pharmacie de Belgique, 53, 172.
Peer Reviewed verified by ORBi

Evrard, B., Chiap, P., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Influence of cyclodextrins on the solubility and the pharmacokinetics of albendazole [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Piel, G., Evrard, B., Fillet, M., Llabres, G., & Delattre, L. (1998). Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. International Journal of Pharmaceutics, 169, 15-22. doi:10.1016/S0378-5173(98)00103-3
Peer Reviewed verified by ORBi

Piel, G., Evrard, B., Van Hees, T., Fernandez del Pozo, C., & Delattre, L. (1998). Development of a sustained release dosage form diclofenac-cyclodextrin inclusion complex [Poster presentation]. IX th International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Evrard, B., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Development and pharmacokinetic evaluation of an oral liquid formulation of albendazole with cyclodextrins [Poster presentation]. 2th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Piel, G., Van Hees, T., Evrard, B., & Delattre, L. (1998). A comparative pharmacokinetic study of intravenous solutions containig miconazole with or without cyclodextrins [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Piel, G., Llabres, G., Fillet, M., Evrard, B., Van Hees, T., & Delattre, L. (1998). A proton nuclear resonance study of the inclusion complex of miconazole with b-cyclodextrin in an acidic medium [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (1998). A comparative study of the dissolution properties of piroxicam-b-cyclodextrin inclusion complexes prepared by different methods [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (1998). Preparation of a drug-b-cyclodextrin inclusion compound using supercritical carbon dioxide [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Piel, G., Evrard, B., & Delattre, L. (July 1997). Study of the combined effects of cyclodextrins and buffer type on the solubility of miconazole [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States.

Evrard, B., Piel, G., Ceccato, A., & Delattre, L. (July 1997). Effects of cyclodextrins on the solubility characteristics of albendazole [Poster presentation]. Pharmaceutical appplication of Cyclodextrins Conference, Lawrence, Kansas, United States.

Piel, G., Fillet, M., Evrard, B., Crommen, J., & Delattre, L. (July 1997). Comparison of the binding constant values of complexes of different antimycotic imidazole derivatives with cyclodextrin obtained by capillary electrophoresis and phase solubility diagram [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States.

Evrard, B., Ceccato, A., Gaspard, O., Delattre, L., & Delporte, J.-P. (01 May 1997). Stability of Ondansetron Hydrochloride and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Injection and in 5% Dextrose Injection. American Journal of Health-system Pharmacy, 54 (9), 1065-8. doi:10.1093/ajhp/54.9.1065
Peer Reviewed verified by ORBi

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Llabres, G., Delarge, J., & Delattre, L. (April 1997). Study of the Influence of Both Cyclodextrins and L-Lysine on the Aqueous Solubility of Nimesulide; Isolation and Characterization of Nimesulide-L-Lysine-Cyclodextrin Complexes. Journal of Pharmaceutical Sciences, 86 (4), 475-80. doi:10.1021/js960298k
Peer Reviewed verified by ORBi

Piel, G., Evrard, B., & Delattre, L. (April 1997). Multicomponent complexes of miconazole with different acids and cyclodextrins [Paper presentation]. VIIth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Duvivier, F., Grandfils, C., Léonard, F., Evrard, B., & Delattre, L. (1997). The size of nanoparticles after their incorporation in gastroresistant spheroids. Journal de Pharmacie de Belgique, 52 (3), 123.
Peer Reviewed verified by ORBi

Duvivier, F., Grandfils, C., Léonard, F., Evrard, B., & Delattre, L. (1997). Development of a nanoparticular oral delivery system : study of the size of the nanoparticles after incorporation into gastroresistant pellets [Paper presentation]. 7th Forum of Pharmaceutical Sciences.

Piel, G., Evrard, B., & Delattre, L. (1997). Complexes à multicomposants de miconazole avec différents acides et cyclodextrines. Journal de Pharmacie de Belgique, 52 (3), 124.

Duvivier, F, Grandfils, C., Léonard, F, Evrard, B., & Delattre, L. (1997). Etude de la taille des nanoparticules après incorporation dans des sphéroïdes gastrorésistants. Journal de Pharmacie de Belgique, 52 (3), 123.
Peer Reviewed verified by ORBi

Duvivier, F., Lübbering, B., Léonard, F., Evrard, B., Goffinet, G., & Delattre, L. (1997). Influence of the amount of enteric polymer on the disintegration rate of pellets designed for protein delivery : in vitro and in vivo tests. In Proceedings of Symposium on Particulate Systems, From Formulation to Prduction.
Peer reviewed

Piel, G., Pochet, L., Delattre, L., & Delarge, J. (April 1996). Study of the influence of g-cyclodextrin on the molsidomine photostability [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary.

Piel, G., Delneuville, I., & Delattre, L. (April 1996). In vitro and in vivo studies on sodium nimesulide-b-cyclodextrin inclusion complexes [Poster presentation]. VIIIth International Cyclodextrin Symposium, Budapest, Hungary.

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (February 1996). Preparation by spray drying of b and g-cyclodextrin inclusion complexes of a poorly soluble non steroidal anti-inflammatory drug [Poster presentation]. Formulation of Poorly-Available Drugs for Oral Administration, European Symposium, Paris, France.

Evrard, B., Ceccato, A., Colson, A., Léonard, F., Gaspard, O., Delporte, J.-P., & Delattre, L. (1996). Stability of ondansetron hydrochloride and dexamethazone sodium phosphate admixtures in injectable solutions [Paper presentation]. Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G., Pirotte, B., Delneuville, I., Neven, P., Delarge, J., & Delattre, L. (1996). Nimesulide-L-lysine-β- and γ-cyclodextrin complexes: preparation and dissolution properties. Journal de Pharmacie de Belgique, 51, 117.
Peer Reviewed verified by ORBi

Evrard, B., & Delattre, L. (1996). In vitro evaluation of lipid matrices for the development of a sustained-release sulfamethazine bolus for lambs. Drug Development and Industrial Pharmacy, 22 (2), 111-118. doi:10.3109/03639049609041980
Peer Reviewed verified by ORBi

Evrard, B., & Delattre, L. (1996). Formes pharmaceutiques à libération prolongée en médecine vétérinaire : systèmes à rétention dans le réticulo-rumen = Sustained-released veterinary dosage forms : retention devices in the reticulorumen. STP Pharma Pratiques, 6 (6), 479-486.
Peer reviewed

Piel, G., Pochet, L., Delattre, L., & Delarge, J. (June 1995). Photostability studies of molsidomine-cyclodextrin complexes [Poster presentation]. Photostability of drugs, 1st International Meeting, Oslo, Norway.

Evrard, B., Hubert, P., Chiap, P., Crommen, J., & Delattre, L. (1995). A fully automated HPLC method for pharmacokinetic studies on a long-acting sulfamethazine veterinary bolus. Journal de Pharmacie de Belgique, 50, 328.
Peer Reviewed verified by ORBi

Evrard, B., Hubert, P., Chiap, P., Crommen, J., & Delattre, L. (1995). A fully automated HPLC method for pharmacokinetic studies on a long-acting sulfamethazine veterinary bolus [Paper presentation]. 5th International Symposium on Drug Analysis, Leuven, Belgium.

Evrard, B., Delahaut, P., Hubert, P., Crommen, J., & Delattre, L. (1995). Biopharmaceutical aspects of the development of a sulfamethazine oral sustained release bolus for lambs. Journal of Controlled Release, 35, 107-115. doi:10.1016/0168-3659(95)00025-4
Peer Reviewed verified by ORBi

Evrard, B., & Delattre, L. (1995). Evaluation of the correlation between "in vitro" and "in vivo" release of sulfamethazine from a long-acting ovine bolus. In Proceedingsof 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (pp. 927-928).
Peer reviewed

Evrard, B., Delahaut, P., & Delattre, L. (1994). Pharmacokinetic evaluation of a long-acting sulfamethazine bolus for lambs. In Proceedings of 21th International Symposium on controlled release of Bioactive Materials.
Peer reviewed

Hubert, P., Chiap, P., Evrard, B., Delattre, L., & Crommen, J. (08 December 1993). Fully Automated Determination of Sulfamethazine in Ovine Plasma Using Solid-Phase Extraction on Disposable Cartridges and Liquid Chromatography. Journal of Chromatography. A, 622 (1), 53-60. doi:10.1016/0378-4347(93)80249-4
Peer Reviewed verified by ORBi

Evrard, B., Peerboom, C., & Delattre, L. (1993). Evaluation of a new laboratory high-shear mixer [Paper presentation]. Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Evrard, B., Dechesne, J.-P., Fagetton, X., & Delattre, L. (1992). Development of a sustained release bolus for sheep : "in vitro" and "in vivo" results. In Proceedings of 19th International Symposium on controlled release of Bioactive Materials (pp. 435-436).
Peer reviewed

Evrard, B., & Delattre, L. (1992). Development of a long acting sulfamethazine bolus for sheep [Paper presentation]. Second European Symposium on Controlled Drug Delivery, Noordwijk aan Zee, Netherlands.

Delneuville, I., Evrard, B., Kapusta, D., Dechesne, J.-P., & Delattre, L. (1992). Développement galénique d'une forme matricielle à libération prolongée renfermant un actif hydrosoluble. In Proceedings of 6th International Conference of Pharmaceutical Technology.
Peer reviewed

Evrard, B., & Delattre, L. (1992). Melt-Granulation with a new laboratory high-shear mixer. In Proceedings of 6th International Conference of Pharmaceutical Technology.
Peer reviewed

Hubert, P., Evrard, B., Delattre, L., & Crommen, J. (1992). Automated determination of sulfadimidine in ovine plasma by solid phase extraction and HPLC. Journal de Pharmacie de Belgique, 47, 197.
Peer Reviewed verified by ORBi

Evrard, B., Dechesne, J.-P., Fagetton, X., Zygraich, N., & Delattre, L. (1992). Development of a long-acting sulfamethazine bolus for sheep. In Proceedings of 6th International Conference of Pharmaceutical Technology (pp. 114-122).
Peer reviewed

Evrard, B., Gougnard, T., & Delattre, L. (March 1991). Cystéamine therapy for children with nephropathic cystinosis : stability of cysteamine in eyedrops and drinkable solutions [Paper presentation]. Forum des Sciences Pharmaceutiques, Houffalize, Belgium.

Evrard, B., Dechesne, J.-P., Fagetton, X., Zygraich, N., & Delattre, L. (March 1990). Development of a sustained release bolus for lambs [Paper presentation]. Forum des Sciences Pharmaceutiques, De Haan, Belgium.

Bontemps, J., Pirson, P., Falmagne, J.-B., Jérôme, R., Theyssie, P., Delattre, L., & Evrard, B. (01 February 1989). MICROPARTICLES COMPRISING A BIODEGRADABLE POLYMER CONTROLLING THE RELEASE OF AN ANTIMALARIAL DRUG, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION.

Evrard, B., Delattre, L., & Dechesne, J.-P. (1987). Stabilité des collyres à base de chlorhydrate de cystéine. Pharmakon, 69, 7-10.
Peer reviewed

Evrard, B., Dechesne, J.-P., & Delattre, L. (December 1986). Influence of propyleneglycol, dimethylisosorbide and isopropylmyristate on in vitro release of an antihistaminic drug from a transdermal therapeutic system [Poster presentation]. Neu-Ulm Conferance on transdermal Drug delivery, Neu Ulm, Germany.

Delattre, L., & Evrard, B. (1985). Mise au point d'une formulation d'un gel topique à base de Dermovate lotion. Journal de Pharmacie de Belgique, 40 (5), 343-344.

Contact ORBi